Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive women
Landolt, N.K.; Phanuphak, N.; Ubolyam, S.; Pinyakorn, S.; Kerr, S.; Ahluwalia, J.; Thongpaeng, P.; Thammajaruk, N.; Cremers, S.; Thomas, T.; Chaithongwongwatthana, S.; Lange, J.M.A.; Ananworanich, J.
Journal of Acquired Immune Deficiency Syndromes 66(2): E50-E52
2014
ISSN/ISBN: 1944-7884 PMID: 24608892 DOI: 10.1097/qai.0000000000000134Document Number: 582055
Document emailed within 0-6 h
Related Documents
Vieira, C.S.; Bahamondes, M.V.; de Souza, R.M.; Brito, M.B.; Rocha Prandini, T.R.; Amaral, E.; Bahamondes, L.; Duarte, G.; Quintana, S.M.; Scaranari, C.; Ferriani, R.A. 2014: Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women Journal of Acquired Immune Deficiency Syndromes 66(4): 378-385Patel, R.C.; Onono, M.; Gandhi, M.; Blat, C.; Hagey, J.; Shade, S.B.; Vittinghoff, E.; Bukusi, E.A.; Newmann, S.J.; Cohen, C.R. 2015: Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study Lancet. HIV 2(11): E474-E482
Ekouevi, D.K.; Coffie, P.A.; Ouattara, E.; Moh, R.; Amani-Bosse, C.; Messou, E.; Sissoko, M.; Anglaret, X.; Eholié, S.P.; Danel, C.; Dabis, F.ço.; Dabis, F.; Bissagnene, E.; Messou, E.; Amani-Bosse, C.; Ba-Gomis, O.; Minga, A.; Balestre, E.; Doring, A.; Ekouévi, D.K.; Jaquet, A.; Leroy, V.; Lewden, C.; Malateste, K.; Rabourdin, E.; Thiebaut, R.; Allou, G.; Azani, J.C.; Coffie, P.A.; Djétouan, H.; Kouadio, B.; Kouakou, A.; Bissagnene, E.; Salamon, R.; Anglaret, X.; Danel, C.; Moh, R.; Sorho, S.; Gabillard, D.; Eholie, S.; Chenal, H.; Minga, A.; Kanga, C.; Messou, E.; Rouet, F.; Anglaret, X.; Eholie, S.; Danel, C.; Moh, R.; Bohoussou, F.; Badjé, A.; N'takpé, J.B.; Ouattara, E.; Lecarrou, J.; Gabillard, D.; Bissagnene, E.; Ba-Gomis, O.;, 2011: Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire Journal of Acquired Immune Deficiency Syndromes 56(2): 183-187
Leticee, N.; Viard, J.-P.; Yamgnane, A.; Karmochkine, M.; Benachi, A. 2012: Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz Contraception 85(4): 425-427
Kappelhoff, B.S.; van Leth, F.; MacGregor, T.R.; Lange, J.; Beijnen, J.H.; Huitema, A.D.R. 2005: Nevirapine and efavirenz pharmacokinetics and covariate analysis in the 2NN study Antiviral Therapy 10(1): 145-155
Casado, J.L.; Moreno, A.; Hertogs, K.; Dronda, F.; Moreno, S. 2002: Extent and importance of cross-resistance to efavirenz after nevirapine failure Aids Research and Human Retroviruses 18(11): 771-775
Bonnet, M.; Bhatt, N.; Baudin, E.; Silva, C.; Michon, C.; Taburet, A.-M.; Ciaffi, L.; Sobry, A.ès.; Bastos, R.; Nunes, E.; Rouzioux, C.; Jani, I.; Calmy, A.; Gudo, P.S.; Okamura, J.é L.M.; Lab, M.L.B.; Barreto, A.; Diallo, A.; Nhadzombo, M.; Sitoe, F.; Nhumaio, D.ár.; Bule, O.; Tandaucane, J.é; Guiloviça, V.ân.; Meggi, B.; Sitoe, N.ád.; Vubil, A. 2013: Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial LANCET. Infectious Diseases 13(4): 303-312
Stöhr, W.; Back, D.; Dunn, D.; Sabin, C.; Winston, A.; Gilson, R.; Pillay, D.; Hill, T.; Ainsworth, J.; Pozniak, A.; Leen, C.; Bansi, L.; Fisher, M.; Orkin, C.; Anderson, J.; Johnson, M.; Easterbrook, P.; Gibbons, S.; Khoo, S. 2008: Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication Antiviral Therapy 13(5): 675-685
Landolt, N.K.; Phanuphak, N.; Ubolyam, S.; Pinyakorn, S.; Kriengsinyot, R.; Ahluwalia, J.; Thongpaeng, P.; Gorowara, M.; Thammajaruk, N.; Chaithongwongwatthana, S.; Lange, J.M.A.; Ananworanich, J. 2013: Efavirenz, in contrast to nevirapine, is associated with unfavorable progesterone and antiretroviral levels when coadministered with combined oral contraceptives Journal of Acquired Immune Deficiency Syndromes 62(5): 534-539
Antinori, A.; Zaccarelli, M.; Cingolani, A.; Forbici, F.; Rizzo, M.G.; Trotta, M.P.; Di Giambenedetto, S.; Narciso, P.; Ammassari, A.; Girardi, E.; De Luca, A.; Perno, C.F. 2002: Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure Aids Research and Human Retroviruses 18(12): 835-838
Scarsi, K.; Lamorde, M.; Darin, K.; Penchala, S.D.; Else, L.; Nakalema, S.; Byakika-Kibwika, P.; Khoo, S.; Cohn, S.; Merry, C.; Back, D. 2014: Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant Journal of the International Aids Society 17(4 Suppl 3: 19484
Coovadia, A.; Abrams, E.J.; Strehlau, R.; Shiau, S.; Pinillos, F.; Martens, L.; Patel, F.; Hunt, G.; Tsai, W.-Y.; Kuhn, L. 2015: Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: a Randomized Clinical Trial JAMA 314(17): 1808-1817
Flys, T.S.; McConnell, M.S.; Matovu, F.; Church, J.D.; Bagenda, D.; Khaki, L.; Bakaki, P.; Thigpen, M.C.; Eure, C.; Fowler, M.Glenn.; Eshleman, S.H. 2008: Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission Journal of Infectious Diseases 198(4): 465-469
Maleewong, U.; Kulsomboon, V.; Teerawattananon, Y. 2008: The cost-effectiveness analysis of initiating HIV/AIDS treatment with efavirenz-based regimens compared with nevirapine-based regimens in Thailand Journal of the Medical Association of Thailand 91(Suppl 2): S126-S138
Zijenah, L.S.; Kadzirange, G.; Rusakaniko, S.; Kufa, T.; Gonah, N.; Tobaiwa, O.; Gwanzura, C.; Matsikire, E.; Katzenstein, D.A. 2006: A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe Central African Journal of Medicine 52(1-2): 1-8
Tantbirojn, P.; Taneepanichskul, S. 2002: Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women Contraception 66(6): 401-405
Mincu, I.; Chişiu, N. 1970: Significant decrease of rapid lipoproteins in the blood serum in patients with jaundice Medicina Interna 22(1): 49-54
Ondrus, J. 1990: Interprofessional cooperation between gynecologists and pathologists in the district of Karviná leading to a significant decrease in the incidence of invasive cancer of the uterine cervix Ceskoslovenska Gynekologie 55(10): 774-776
Mornar, S.; Chan, L.-N.; Mistretta, S.; Neustadt, A.; Martins, S.; Gilliam, M. 2012: Pharmacokinetics of the etonogestrel contraceptive implant in obese women American Journal of Obstetrics and Gynecology 207(2): 110.E1-6
Østergaard, L.R.; Bula, A. 2010: "They call our children "Nevirapine babies?" ": a qualitative study about exclusive breastfeeding among HIV positive mothers in Malawi African Journal of Reproductive Health 14(3): 213-222